Le Lézard
Classified in: Business, Covid-19 virus
Subjects: ERN, PDT, ACC

ADAMA Delivers First Quarter Business Growth Despite COVID-19 pandemic


BEIJING and TEL AVIV, Israel, April 27, 2020 /PRNewswire/ -- ADAMA Ltd. (the "Company") (SZSE: 000553), today reported its financial results for the first quarter ended March 31, 2020.

During the first quarter of 2020, the global agrochemical market, amongst many others, was impacted by the unprecedented coronavirus pandemic, COVID-19. The pandemic, which started early in the quarter and now continues to rage throughout the rest of the world, has had a number of adverse effects on ADAMA's performance in the first quarter, the most significant of which were:

The ongoing spread of the pandemic is expected to continue to negatively impact the performance of the Company in the second quarter, and potentially beyond. The Company is actively managing its response to the outbreak in order to ensure the safety of its employees and limit the impact on the Company's performance. Actions being taken include extending and strengthening distribution channels, use of expedited transport options where possible, working collaboratively with supply chain partners, and raising prices wherever possible to accommodate the weaker currencies and increased logistics costs.

Ignacio Dominguez, President and CEO of ADAMA, said, "Our resilient performance and continued business growth in the quarter was achieved in the face of the unprecedented coronavirus pandemic, which is significantly changing the way we live our lives, while also causing major disruption to global trade, including the currency markets, amongst many others. During this troubling and uncertain period, I am very proud of the response of our teams across the globe to ensure the health and safety of our employees, and mitigate the impact of the pandemic on our business."

Table 1. Financial Performance Summary

CER: Constant Exchange Rates

All income statement items contained in this release are presented on an adjusted basis. A detailed description and analysis of differences between the adjusted income statement and that reported in the financial statements is contained in the "Analysis of Gaps between Adjusted Income Statement and Income Statement in Financial Statements" in the appendix to this release. EPS are the same for basic and diluted.

Adjusted, US$ millions


Q1 2020

Q1 2019


%

Change

CER

Currency Impact

%

Change

USD

Revenues


973

1,006


+1.6%

-50

-3.4%

Gross profit


289

344


-4.8%

-39

-16.0%

Gross margin


29.7%

34.2%





Operating income (EBIT)


82

127


-8.4%

-34

-35.4%

EBIT margin


8.4%

12.6%





Net income


27

80



-62

-66.3%

Net income margin


2.8%

8.0%





EBITDA


142

187


-6.1%

-34

-24.1%

EBITDA margin


14.6%

18.6%





Earnings per share    ?    USD


0.0110

0.0327





                                       ?    RMB


0.0766

0.2207





Financial Highlights

Revenues in the first quarter were $973 million, up 2% at constant exchange rates, with continued business growth in the face of the COVID-19 pandemic. Constant currency sales were constrained by an estimated $47 million due to the COVID-19 pandemic. In addition, sales were heavily impacted by the depreciation of global currencies, resulting in sales in US dollar terms being 3% below those of the same period last year. 

The Company delivered solid business growth in Europe, driven by a strong performance in Eastern European countries, as well as throughout the India, Middle East & Africa region supported by favorable weather conditions in key areas. In Latin America, the Company has grown its sales in constant currency terms, strengthened by its recent acquisition in Peru, but sales in US dollar terms were impacted by the depreciation of regional currencies, most notably the Brazilian Real. Sales in North America were lower largely due to the impact of the coronavirus on demand for the Company's Consumer & Professional products. In Asia-Pacific (excluding China), a strong performance in Australia, which has begun to see a recovery from the extreme drought conditions of the past few years, largely compensated for a coronavirus-driven slowdown in East-Asian markets and the depreciation of local currencies.

In China, despite seeing continued growth in the sales of the Company's branded, formulated products, overall sales in the country were impacted by lower sales of intermediates and unformulated products, mainly those produced at the Jingzhou site which was temporarily suspended during the quarter.

Gross profit in the first quarter was $289 million (gross margin of 29.7%), compared to $344 million (gross margin of 34.2%) in the corresponding period last year. The lower gross margin was mainly a result of the material depreciation of global currencies, alongside some pricing pressure, mainly in Europe and China, and sustained high procurement costs, all of which were only partially offset by the business growth achieved in the quarter.

Operating expenses. Total operating expenses in the first quarter were $207 million (21.2% of sales), compared to $218 million (21.6% of sales) in the corresponding period last year. The Company continues to exercise tight control of its operating expenses, assisted by the beneficial impact of the strengthening of the US dollar against global currencies, achieving significant savings even while including companies acquired during 2019. The first quarter this year also saw the recording of Jingzhou-related idleness costs resulting from the temporary suspension of operations there due to the coronavirus outbreak in an amount similar to those recorded also during Q1 2019 when the sites were similarly suspended, while the first quarter last year also benefited from income related to expropriation of land.

Operating income in the quarter was $82 million (8.4% of sales), compared to $127 million (12.6% of sales) in the corresponding period last year. The widespread currency depreciation, due to the coronavirus outbreak among other factors, constrained operating income by $34 million in the quarter.

EBITDA in the quarter was $142 million (14.6% of sales), compared to $187 million (18.6% of sales) recorded in the corresponding period last year. The lower EBITDA in the quarter was driven by the lower gross profit, which was partially offset by the reduction in operating expenses. The COVID-19 pandemic constrained Q1 EBITDA by an estimated $20 million, in addition to the $34 million in currency headwinds due, amongst other factors, to the coronavirus outbreak.

Financial expenses and investment income. Total net financial expenses and investment income were $31 million in the first quarter, compared to $37 million in the corresponding period last year. The lower financial expenses in the quarter reflect financial income earned due to the effect of the appreciation of the US dollar against the RMB on the value of US dollar-denominated monetary assets in China, while the higher expenses in the prior year resulted from the opposite. This financial income in the quarter more than offset the slightly increased interest costs on higher net debt levels.

Tax expenses. Net tax expenses were $24 million in the first quarter, compared to $9 million in the corresponding period last year. The higher expense was largely due to the impact of weakening of currencies against the US dollar, most notably that of the Brazilian Real, driving higher non-cash tax expenses due to differences between the functional (US dollar) and tax (local) currencies regarding the value of non-monetary assets.

Net income in the first quarter was $27 million (2.8% of sales) compared to $80 million (8.0% of sales) recorded in the corresponding period last year, reflecting the lower operating income and higher tax expenses. The COVID-19 pandemic constrained Q1 Net Income by an estimated $17 million, in addition to the $62 million impact of global currency movements.

Trade working capital at March 31, 2020 was $2,178 million, compared to $2,082 million at the same point last year. The slightly higher level reflects higher trade receivables and lower trade payables, which were partially offset by lower inventory levels. The higher trade receivables were driven largely by the Company's strong growth over the last year in Latin America, especially Brazil, where customer credit terms are generally longer. Although trade payables were somewhat lower in comparison to their levels a year ago, they were significantly improved over the course of the quarter, contributing to the improvement in operating cash flow.

Cash Flow. Operating cash flow of $55 million was consumed in the first quarter, compared to $191 million consumed in the corresponding period last year. The improved operating cash flow in the quarter mainly reflects the improvement in working capital during the quarter compared to the parallel period last year.

Net cash used in investing activities was $53 million in the first quarter, compared to $159 million in the corresponding period last year which included the acquisition of Bonide.

Free cash flow of $116 million was consumed in the first quarter compared to $355 million consumed in the same period last year, reflecting the improvement in operating cash flow in the first quarter of this year, contrasted with the higher investment levels and acquisitions of the same period in 2019.

Leverage: Balance sheet net debt at March 31, 2020 stood at $1,189 million, compared to $875 million as at March 31, 2019, largely reflecting the 2019 acquisitions and the assumption of their debt, as well as capital investments in portfolio expansion and the Company's other growth engines.

Regional Sales Performance

CER: Constant Exchange Rates



Q1 2020

$m

Q1 2019

$m


Change

CER

Change

USD

Europe


357

360


+2.7%

-1.0%

North America


168

180


-6.0%

-6.7%

Latin America


159

159


+12.5%

-0.3%

Asia Pacific


158

186


-9.8%

-14.9

 Of which, China


68

94


-24.6%

-27.1%

India, Middle East & Africa


131

121


+12.5%

+8.3%

Total


973

1,006


+1.6%

-3.4%

Europe: Sales increased by 2.7% in the first quarter at constant exchange rates, compared with the corresponding period last year, driven by continued business growth, partially offset by lower prices resulting from high inventory levels in the industry's distribution channels.

In Northern Europe, ADAMA saw pleasing business growth in the quarter, partially recovering from supply constraints seen in 2019 that affected key products. The Company delivered robust growth in most Eastern European countries supported by favorable weather conditions, with noteworthy performances recorded in Russia and Ukraine, where the Company is seeing continued market share gains, as well as Hungary and Romania, which benefited from an early start to the 2020 season. In addition, the Company grew in the key western European markets of France and Italy.

In US dollar terms, sales in Europe were lower by 1.0% in the quarter, compared to the corresponding period last year, reflecting the net impact of weaker currencies, largely due to the coronavirus outbreak.

North America: Sales in the quarter were lower by 6.0%, at constant exchange rates, compared to the corresponding period last year, largely due to the impact of the coronavirus which reduced demand for the Company's Consumer & Professional (non-crop) products.

The Company recorded strong business growth in Canada with solid demand for crop protection products, as well as favorable weather conditions. In the US, ADAMA obtained two new rice herbicide registrations in the quarter, enhancing its portfolio of solutions for conventional rice and complementing ADAMA's Prefacetm and Postscripttm herbicides for the FullPagetm Rice Cropping Solution, furthering the Company's offering to rice farmers.

In US dollar terms, sales in North America were lower by 6.7% in the quarter, compared to the corresponding period last year, reflecting the coronavirus-related weakening of the Canadian Dollar.

Latin America: Sales grew by 12.5% in the first quarter, at constant exchange rates, compared to the corresponding period last year. The robust performance was driven by strong business growth, bolstered by the Company's recent acquisition in Peru, alongside continued price increases.

The Company saw continued constant-currency business growth in Brazil in the quarter, despite drought conditions which delayed the planting season in key crops including soybean and reduced application of fungicides. Noteworthy performances were also recorded in the quarter in Mexico, benefiting from good weather conditions particularly in the Pacific region, as well as Colombia and Ecuador, driven by a good harvest season in key crops.

ADAMA continues to expand its differentiated product offering in the region with the launch during the quarter of EMINENT®, a dual mode broad-spectrum insecticide, in Argentina. The Company also obtained the registration of UBERTOP®, an insecticide used mainly for the control of a wide range of pests in tomato and cabbage, in Mexico.

In US dollar terms, sales in Latin America were lower by 0.3% in the quarter, compared to the corresponding period last year, reflecting the significant depreciation of regional currencies, most notably the Brazilian Real, as a result of the coronavirus outbreak.

Asia-Pacific: Sales were lower by 9.8% in the quarter, at constant exchange rates, compared to the corresponding period last year, due largely to the outbreak of the COVID-19 pandemic, which started early in the quarter.

In Asia-Pacific (excluding China), a strong performance in Australia, which has begun to see a recovery from the extreme drought conditions of the past few years, largely compensated for a coronavirus-driven slowdown in East-Asian markets. In China, despite seeing continued growth in the sales of the Company's branded, formulated products, overall sales in the country were impacted by the coronavirus outbreak which resulted in logistics and supply challenges, and reduced sales of intermediates and unformulated products from the temporarily suspended Jingzhou site.

During the quarter, the Company launched new products including QUALIPRO ENCLAVE®, a quadruple-mode of action fungicide mixture for use in turf in Australia, and obtained multiple new product registrations in the region, including BALORIC® and SOLITO®, an early post-emergence rice herbicide, in Thailand and Indonesia. 

In US dollar terms, sales in Asia-Pacific were lower by 14.9% in the quarter, compared to the corresponding period last year, reflecting the impact of weaker currencies following the coronavirus outbreak.

India, Middle East & Africa: Sales in the first quarter grew by 12.5%, at constant exchange rates, compared to the corresponding period last year. The Company recorded robust business growth in all major markets throughout the region, alongside increased prices, despite the impact of the missing sales of Jingzhou old site products resulting from the temporary suspension of operations there due to the coronavirus outbreak.

ADAMA delivered solid business growth in India combined with higher pricing, in spite of a countrywide lockdown enforced by the Indian government that commenced towards the end of the quarter. The Company also grew strongly in South Africa and Israel, benefiting from favorable weather conditions, and delivered pleasing results in Turkey from where the Company is also expanding its presence into surrounding countries in the region.

In US dollar terms, sales in the region grew by 8.3% in the quarter, compared to the corresponding period last year, reflecting the impact of softer currencies, which were adversely affected by the coronavirus outbreak, most notably the Turkish Lira and the Indian Rupee.

2017 ADAMA-Sanonda Combination: Value Adjustment Mechanism

Within the context of the 2017 combination between Hubei Sanonda Co. Ltd. ("Sanonda", as it was then known) and Adama Agricultural Solutions Ltd. ("Solutions"), the Company entered into a Performance Compensation Agreement with CNAC, then the 100% owner of Solutions and the controlling shareholder of Sanonda. Under this agreement, CNAC made a commitment regarding Solutions' aggregate net profit in 2017, 2018 and 2019. In case of failure to meet the commitment, CNAC is required to compensate the Company either through shares or cash according to a predetermined formula. The aggregate net profit commitment for the 2017-2019 period, as agreed to by CNAC, was an amount of $543.4 million. Despite Solutions' strong performance during the three-year period, due to exogenous reasons, the calculated net profit of Solutions for this period has now been determined to be approximately $512.7 million, implying a shortfall of approximately $30.7 million. This shortfall was caused entirely by the impact of the Divestment & Transfer of several products that Solutions implemented to facilitate the approval by the EU Commission of the acquisition of Syngenta by ChemChina, which caused an aggregate of $66 million in incremental non-cash amortization charges related to the written-up value of the assets received from Syngenta. Absent these non-cash amortization charges, Solutions would have exceeded the profit commitment by approximately $35 million.

As a result, CNAC will be required to return to the Company 102,432,280 out of the 1,810,883,039 shares it received in the Company in exchange for the transfer of 100% of Solutions to the Company in 2017, and return the relevant portion of the dividends it received in respect of such shares. Following their receipt, these shares will be canceled by the Company. As a result, the total number of shares in issue will be reduced to 2,344,121,302, and CNAC's aggregate ownership in the Company will reduce from 78.9% to 78.0%.

In addition to the profit commitment, and as required by the relevant regulation, an independent valuation of Solutions' has been performed in order to assess any potential diminution in the value of Solutions. Following the performance of such valuation, it has been determined that no such diminution has occurred.

Revenues by operating segment

First quarter sales by segment


Q1 2020

USD(m)

%


Q1 2019

USD(m)

%

Crop Protection

885

91.0%


910

90.4%

Intermediates and Ingredients

88

9.0%


97

9.6%

Total

973

100.0%


1,006

100.0%

 

First quarter sales by product category


Q1 2020

USD(m)

%


Q1 2019

USD(m)

%

Herbicides

441

45.3%


458

45.5%

Insecticides

217

22.3%


268

26.6%

Fungicides

227

23.3%


184

18.3%

Intermediates and Ingredients

88

9.0%


97

9.6%

Total

973

100.0%


1,006

100.0%

Note: the sales split per product category is provided for convenience purposes only, and is not representative of the way the Company is managed or in which it makes its operational decisions.

Further Information

All filings of the Company, together with a presentation of the key financial highlights of the period, can be accessed through the Company website at www.adama.com.

Abridged Consolidated Financial Statements

The following abridged consolidated financial statements and notes have been prepared as described in Note 1. While prepared based on the principles of PRC GAAP, they do not contain all of the information which either PRC GAAP or IFRS would require for a complete set of financial statements and should be read in conjunction with the consolidated financial statements of both ADAMA Ltd. and Adama Agricultural Solutions Ltd. as filed with the Shenzhen and Tel Aviv Stock Exchanges, respectively.

Abridged Consolidated Income Statement for the First Quarter

The number of shares used to calculate both basic and diluted earnings per share is 2,446.6 million shares.

Adjusted[1]

Q1 2020

USD(m)

Q1 2019

USD(m)

Q1 2020

RMB(m)

Q1 2019

RMB(m)

Revenues

973

1,006

6,782

6,788

Cost of Sales

681

659

4,750

4,442

Business taxes and surcharges

3

4

19

25

Gross profit

289

344

2,013

2,321

% of revenue

29.7%

34.2%

29.7%

34.2%

Selling & Distribution expenses

159

164

1,106

1,103

General & Administrative expenses

28

32

194

217

Research & Development expenses

13

14

92

96

Other

7

8

48

52

Total operating expenses

207

218

1,440

1,468

% of revenue

21.2%

21.6%

21.2%

21.6%

Operating income (EBIT)

82

127

573

853

% of revenue

8.4%

12.6%

8.4%

12.6%

Financial expenses and investment income

31

37

217

252

Income before taxes

51

89

356

601

Taxes on Income

24

9

169

61

Net income

27

80

187

540

% of revenue

2.8%

8.0%

2.8%

8.0%

EBITDA

142

187

993

1,264

% of revenue

14.6%

18.6%

14.6%

18.6%

Earnings per Share   ? Basic

0.0110

0.0327

0.0766

0.2207

                                      ? Diluted

0.0110

0.0327

0.0766

0.2207

Abridged Consolidated Balance Sheet


March 31

2020

USD (m)

March 31

2019

USD (m)


March 31

2020

RMB (m)

March 31

2019

RMB (m)

Assets






Current assets:






Cash at bank and on hand

602

713


4,264

4,801

Bills and accounts receivable

1,414

1,344


10,019

9,052

Inventories

1,424

1,482


10,091

9,979

Other current assets, receivables and
prepaid expenses

461

290


3,264

1,949

Total current assets

3,901

3,829


27,638

25,781

Non-current assets:






Fixed assets, net

1,099

1,134


7,786

7,637

Rights of use assets

75

79


534

534

Intangible assets, net

1,455

1,497


10,308

10,077

Deferred tax assets

118

119


833

801

Other non-current assets

96

100


681

674

Total non-current assets

2,843

2,929


20,142

19,723

Total assets

6,744

6,758


47,780

45,504







Liabilities






Current liabilities:






Loans and credit from banks and
other lenders

507

390


3,595

2,627

Bills and accounts payable

680

767


4,814

5,163

Other current liabilities

813

796


5,760

5,358

Total current liabilities

2,000

1,953


14,169

13,148

Long-term liabilities:






Long-term loans from banks and other
lenders

167

70


1,181

472

Debentures

1,101

1,147


7,804

7,723

Deferred tax liabilities

63

56


448

380

Employee benefits

97

87


687

588

Other long-term liabilities

140

141


991

950

Total long-term liabilities

1,568

1,501


11,111

10,113

Total liabilities

3,568

3,454


25,280

23,261







Equity






Total equity

3,176

3,304


22,500

22,243

Total equity

3,176

3,304


22,500

22,243

Total liabilities and equity

6,744

6,758


47,780

45,504

Abridged Consolidated Cash Flow Statement for the First Quarter


Q1 2020

USD (m)

Q1 2019

USD (m)


Q1 2020

RMB (m)

Q1 2019

RMB (m)

Cash flow from operating activities:






Cash flow from operating activities

-55

-191


-385

-1,232

Cash flow from operating activities

-55

-191


-385

-1,232







Investing activities:






Acquisitions of fixed and intangible assets

-51

-43


-357

-321

Proceeds from disposal of fixed and intangible assets

1

5


9

31

Acquisition of subsidiaries

-

-122


-

-825

Other investing activities

-3

1


-25

10

Cash flow used for investing activities

-53

-159


-373

-1,105







Financing activities:






Receipt of loans from banks and other lenders

171

228


1,194

1,358

Repayment of loans from banks and other lenders

-61

-38


-429

-110

Other financing activities

-20

-66


-136

-426

Cash flow from (used for) financing activities

90

124


629

823

Effects of exchange rate movement on cash and cash
equivalents

-3

5


47

-78

Net change in cash and cash equivalents

-21

-221


-82

-1,593

Cash and cash equivalents at the beginning of the period

619

925


4,320

6,043

Cash and cash equivalents at the end of the period

598

704


4,238

4,450







Free Cash Flow

-116

-355


-805

-2,394

Free Cash Flow excl. acquisitions

-116

-232


-805

-1,569

Notes to Abridged Consolidated Financial Statements

Note 1: Basis of preparation

Basis of presentation and accounting policies: The abridged consolidated financial statements for the quarters ended March 31, 2020 and 2019 incorporate the financial statements of ADAMA Ltd. and of all of its subsidiaries (the "Company"), including Adama Agricultural Solutions Ltd. ("Solutions") and its subsidiaries.

The Company has adopted the Accounting Standards for Business Enterprises issued by the Ministry of Finance (the "MoF") and the implementation guidance, interpretations and other relevant provisions issued or revised subsequently by the MoF (collectively referred to as "CASBE"). 

The abridged consolidated financial statements contained in this release are presented in both Chinese Renminbi (RMB), as the Company's shares are traded on the Shenzhen Stock Exchange, as well as in United States dollars ($) as this is the major currency in which the Company's business is conducted. For the purposes of this release, a customary convenience translation has been used for the translation from RMB to US dollars, with Income Statement and Cash Flow items being translated using the quarterly average exchange rate, and Balance Sheet items being translated using the exchange rate at the end of the period.

The preparation of financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimated.

Note 2: Abridged Financial Statements

For ease of use, the Financial Statements shown in this release have been abridged as follows:

Abridged Consolidated Income Statement:

Abridged Consolidated Balance Sheet:


Analysis of Gaps between Adjusted Income Statement and Reported Income Statement in Financial Statements

Q1

Adjusted

Adjustments

Reported

USD(m)

Q1 2020

Q1 2019

Q1 2020

Q1 2019

Q1 2020

Q1 2019

Revenues

973

1,006

-

-

973

1,006

Gross profit

289

344

1

1

288

343

Operating expenses

207

218

-30

-29

237

247

Operating income (EBIT)

82

127

31

30

51

97

Income before taxes

51

89

31

28

20

61

Net income

27

80

29

26

-2

54

EBITDA

142

187

9

5

133

183

Earnings per share

0.0110

0.0327



-0.0010

0.0222

 

Q1

Adjusted

Adjustments

Reported

RMB(m)

Q1 2020

Q1 2019

Q1 2020

Q1 2019

Q1 2020

Q1 2019

Revenues

6,782

6,788

-

-

6,782

6,788

Gross profit

2,013

2,321

7

7

2,006

2,314

Operating expenses

1,440

1,468

-212

-195

1,652

1,663

Operating income (EBIT)

573

853

219

202

354

651

Income before taxes

356

601

219

186

137

415

Net income

187

540

204

173

-17

367

EBITDA

993

1,264

65

32

928

1,232

Earnings per share

0.0766

0.2207



-0.0068

0.1499

Income Statement Adjustments


Q1 2020

USD (m)

Q1 2019

USD (m)


Q1 2020

RMB (m)

Q1 2019

RMB (m)

Net Income (Reported)

-2.4

54.4


-16.7

366.8

Adjustments to COGS & Operating Expenses:






1.  Amortization of Legacy PPA of 2011 acquisition of Solutions (non-
    cash)

11.5

11.5


79.9

77.2

2.  Amortization of Transfer assets received and written-up due to 2017
    ChemChina-Syngenta transaction (non-cash)

7.9

10.6


54.9

71.7

3.  China Relocation & Upgrade related costs

0.9

2.3


6.3

15.5

4.  Long-term incentive (non-cash)

0.7

4.7


5.1

31.9

5.  Amortization of acquisition-related PPA (non-cash)

1.8

0.9


12.9

6.1

6.  Employee early retirement expenses

8.6

-


59.8

-

Total Adjustments to Operating Income (EBIT)

31.4

30.0


218.9

202.4

Total Adjustments to EBITDA

9.3

4.7


64.9

31.9

Adjustments to Financing Expenses:






7.  Revaluation of non-cash adjustment related to non-controlling
     interest

-

-2.4


-

-16.1

Total Adjustments to Income before Taxes

31.4

27.6


218.9

186.3

Adjustments to Taxes






1.  Tax shield on Legacy PPA of 2011 acquisition of Solutions

-1.9

-1.9


-13.6

-13.1

5.  Deferred tax due to PPA

-0.2

-


1.1

-

Total adjustments to Net Income

29.3

25.7


204.1

173.2

Net Income (Adjusted)

26.9

80.1


187.5

540.0

Notes:

1.  Amortization of Legacy PPA of 2011 acquisition of Solutions (non-cash): Under PRC GAAP, the Company has inherited the historical "legacy" amortization charge from the first combined reporting for Q3 2017 that ChemChina previously was incurring in respect of its acquisition of Solutions in 2011. This amortization is done in a linear manner on a quarterly basis, most of which will be completed and removed in the second half of 2020.

2.  Amortization of Transfer assets received and written-up due to 2017 ChemChina-Syngenta transaction (non-cash): The proceeds from the Divestment of crop protection products in connection with the approval by the EU Commission of the acquisition of Syngenta by ChemChina, net of taxes and transaction expenses, were paid to Syngenta in return for the transfer of a portfolio of products in Europe of similar nature and economic value. Since the products acquired from Syngenta are of the same nature and with the same net economic value as those divested, and since in 2018 the Company excluded the one-time gain that it made on the divested products, the additional amortization charge incurred due to the written-up of the acquired assets is also excluded to present a consistent view of Divestment and Transfer transactions, which had no net impact on the underlying economic performance of the Company.

3.  China Relocation & Upgrade related costs: These are non-cash accelerated depreciation charges related to the three-year Relocation & Upgrade program in China. Production assets located in the old production sites in Jingzhou and Huai'An will be relocated to the new sites in the coming years. Since some of the older production assets may not be able to be relocated, their economic life has been shortened and therefore will be depreciated over a shorter period. Since these are older assets that were built many years ago and will be replaced by newer production facilities at the new sites, and since the ongoing operations of the business will not be impacted thereby, the Company adjusts for the impact of the accelerated depreciation of these assets.

4.  Long-term Incentive (non-cash): The Company granted its employees, who are mainly non-Chinese residents, a long-term incentive (LTI) in the form of 'phantom' options, due to the complexity of granting Chinese-listed, equity-settled options to non-Chinese employees. As such, the Company records an expense, or recognizes income, depending on the fluctuation in the Company's share price, even though the Company will not incur any cash impact prior to exercise of the phantom options. To neutralize the impact of such share price movements on the measurement of the Company's performance and expected employee compensation and to reflect the existing phantom options, in the Company's adjusted financial performance, the LTI is presented on an equity-settled basis in accordance with the value of the existing plan at the grant date.

5.  Amortization of acquisition-related PPA (non-cash): Related to the amortization of non-cash intangible assets created as part of the allocation of the purchase price (PPA) on acquisitions; has no impact on the ongoing performance of the companies acquired.

6.  Employee early retirement expenses: Provision for early retirement plan of employees at one of the Israeli manufacturing sites

7.  Revaluation of non-cash adjustment related to non-controlling interest: Relates to put options issued to non-controlling interests as part of historical business combinations which took place before January 1, 2010. The put options are presented as a liability at the present value of the future exercise price. The revaluation of these put options in Solutions is recognized under IFRS to Goodwill, but due to the acquisition of Solutions by the Company in 2017, which is treated from an accounting perspective as a "Business Combination Under Common Control", such revaluation is recorded as a profit or loss item in the financial reports of the Company. The revaluations of such put options have no bearing on the ongoing performance of the Company and are therefore adjusted for.

Exchange Rate Data for the Company's Principal Functional Currencies


March 31


Q1 Average


2020

2019

Change


2020

2019

Change


EUR/USD

1.094

1.123

(2.6%)


1.102

1.136

(3.0%)


USD/BRL

5.199

3.897

(33.4%)


4.458

3.771

(18.2%)


USD/PLN

4.147

3.837

(8.1%)


3.920

3.790

(3.4%)


USD/ZAR

17.89

14.64

(22.2%)


15.351

14.018

(9.5%)


AUD/USD

0.609

0.708

(14.0%)


0.658

0.713

(7.7%)


GBP/USD

1.234

1.303

(5.3%)


1.234

1.302

(5.3%)


USD/ILS

3.565

3.632

1.8%


3.565

3.644

2.2%


USD LIBOR 3M

1.45%

2.60%

(44.2%)


1.53%

2.69%

(43.1%)


 


March 31


Q1 Average


2020

2019

Change


2020

2019

Change


USD/RMB

7.085

6.734

5.2%


6.974

6.744

3.4%


EUR/RMB

7.751

7.561

2.5%


7.687

7.660

0.3%


RMB/BRL

0.734

0.579

(26.8%)


0.639

0.559

(14.3%)


RMB/PLN

0.585

0.570

(2.7%)


0.562

0.562

(0.0%)


RMB/ZAR

2.525

2.174

(16.1%)


2.201

2.079

(5.9%)


AUD/RMB

4.317

4.770

(9.5%)


4.586

4.806

(4.6%)


GBP/RMB

8.742

8.774

(0.4%)


8.926

8.784

1.6%


RMB/ILS

0.503

0.539

6.7%


0.501

0.540

7.2%



[1] For an analysis of the differences between the adjusted income statement items and the income statement items as reported in the financial statements, see below "Analysis of Gaps between Adjusted Income Statement and Income Statement in Financial Statements".

About ADAMA

ADAMA Ltd. is a global leader in crop protection, providing solutions to farmers across the world to combat weeds, insects and disease. ADAMA has one of the widest and most diverse portfolios of active ingredients in the world, state-of-the art R&D, manufacturing and formulation facilities, together with a culture that empowers our people in markets around the world to listen to farmers and ideate from the field. This uniquely positions ADAMA to offer a vast array of distinctive mixtures, formulations and high-quality differentiated products, delivering solutions that meet local farmer and customer needs in over 100 countries globally. For more information, visit us at www.ADAMA.com and follow us on Twitter® at @ADAMAAgri.

Ben Cohen                                             
Global Investor Relations                         
Email: [email protected]                             

Zhujun Wang
China Investor Relations
Email: [email protected] 

SOURCE ADAMA Ltd.


These press releases may also interest you

at 08:40
Stratus Properties Inc. , a diversified real estate company with holdings, interests and operations in the Austin, Texas area and other select markets in Texas, today reported year ended December 31, 2023 results. Highlights and Recent...

at 08:36
Planet Home Lending, a premier national mortgage lender, servicer, and asset manager, has hired Andy Insua as Regional Sales Manager for the Southeast. With a diverse financial services background in consumer finance, commercial banking, and mortgage...

at 08:35
Zoetis Inc. will host a webcast and conference call at 8:30 a.m. (ET) on Thursday, May 2, 2024. Chief Executive Officer Kristin Peck and Executive Vice President and Chief Financial Officer Wetteny Joseph will review first quarter 2024 financial...

at 08:35
Atara Biotherapeutics, Inc. , a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today reported financial...

at 08:34
Kruze Consulting, the startup accounting and CFO consulting firm servicing more than 800 venture funded startup clients, has released new data on how startups have changed their banking strategies a year after the SVB collapse. According to the data,...

at 08:34
RapidVerify, a provider of identity verification solutions, today announced it has become an authorized E-Verify Employer Agent. This designation underscores RapidVerify's commitment to streamlined and reliable employment eligibility verification for...



News published on and distributed by: